The interface of depression and cardiovascular disease: Therapeutic implications

Annals of the New York Academy of Sciences

Volumn 1345, Issue 1, 2015, Pages 25-35

  Seligman, Fred ^a   Nemeroff, Charles B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Cardiovascular disease; Depression; Mood disorders; Platelets

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; CORONARY ARTERY BYPASS SURGERY; DEPRESSION; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; PASSIVE SMOKING; PLATELET REACTIVITY; SYSTOLIC HYPERTENSION; THROMBOCYTE ACTIVATION; ANIMAL; BEHAVIOR; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY DISEASE; DEPRESSIVE DISORDER; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BEHAVIOR; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DEPRESSION; DEPRESSIVE DISORDER; HEART RATE; HUMANS;

EID: 84943381973     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12738     Document Type: Article

References (70)

1. Maltzberg, B. 1937. Mortality among patients with involutional melancholia. Am. J. Psychiatr. 93: 1231-1238.
2. Mavrides, N., & C.B. Nemeroff . 2013. Treatment of depression in cardiovascular disease. Depress. Anx. 30: 328-341.
3. Weeke, A. 1979. Prevention and Treatment of Affective Disorders. Schou, M., Stromgen, E., Eds.: 289-299. London: Academic Press.
4. Anda, R., D. Williamson, D. Jones, et al. 1993. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4: 285-294.
5. Wulsin, L.R., & B.M. Singal . 2003. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom. Med. 65: 201-210.
6. Pratt, L.A., D.E. Ford, R.M. Crum, et al. 1996. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 94: 3123-3129.
7. Barefoot, J.C., & M. Schroll . 1996. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93: 1776-1780.
8. Schulz, R., S.R. Beach, D.G. Ives, et al. 2000. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Ingern. Med. 160: 1761-1768.
9. Hippisley-Cox, J., K. Fielding, & M. Pringle . 1998. Depression as a risk-factor for ischaemic heart disease in men: population based case-control study. BMJ. 316: 1714-1719.
10. Ford, D.E., L.A. Mead, & P.P. Chang, et al. 1998. Depression is a risk factor for coronary heart disease in men: the precursors study. Arch. Intern. Med. 158: 1422-1426.
11. Ferketich, A.K., J.A. Schwartzbaum, D.J. Frid, et al. 2000. Depression as a antecedent to heart disease among women and men in the NHANES 1 study. National Health and Nutrition Examination Survey. Arch. Intern. Med. 8: 1261-1268.
12. Ariyo, A.A., . M. Haan, C.M. Tangen, et al. 2000. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102: 1773-1779.
13. Aromaa, A., R. Raitasalo, A. Reunanen, et al. 1994. Depression and cardiovascular diseases. Acta. Psychiatr. Scand. Suppl. 377: 77-82.
14. Everson, S.A., D.E. Goldberg, G.A. Kaplan, et al. 1996. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58: 113-121.
15. Jiang, W., R.R. Krishnan, & C.M. O'Connor . 2002. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 16: 111-127.
16. Abramson, J., A. Berger, H.M. Krumholz, et al. 2001. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch. Intern. Med. 161: 1725-1730.
17. Wassertheil-Smoller, S., W.B. Applegate, K. Berge, et al. 1996. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the elderly). Arch. Intern. Med. 156: 553-561.
18. Dong, M., W.H. Giles, V.J. Felitti, et al. 2004. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation 110: 1761-1766.
19. Mannie, Z.N., C. Williams, J. Diesch, et al. 2013. Cardiovascular and metabolic risk profile in young people at familial risk of depression. Br. J. Psychiatr. 203: 18-23.
20. Frasure-Smith, N., F. Lesperance, & M. Talajic . 1994. Depression following myocardial infarction. Impact on 6-month survival. J. Am. Med. Acad. 271: 1082.
21. Frasure-Smith, N., F. Lesperance, & M. Talajic . 1998. Depression and 18-month prognosis after myocardial infarction. Circulation 97: 708.
22. Lesperance, F., N. Frasure-Smith, M. Talajic, et al. 2002. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105: 1049-1053.
23. Ziegelstein, R.C. 2001. Depression in patients recovering from a myocardial infarction. J. Am. Med. Acad. 286: 1621-1627.
24. Bush, D.E., R.C. Ziegelstein, M. Tayback, et al. 2001. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 88: 337-341.
25. Blumenthal, J.A., H.S. Lett, M.D. Babyak, et al. 2003. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362: 604-609.
26. Gonzalez, M.B., T.B. Snyderman, J.T. Colket, et al. 1996. Depression in patients with coronary artery disease. Depression 4: 57-62.
27. Frasure-Smith, N., & F. Lesperance . 2008. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch. Gen. Psychiatr. 65: 62-71.
28. O'Connor, C.M., W. Jiang, M. Kuchibhatla, et al. 2008. Antidepressant use, depression, and survival in patients with heart failure. Arch. Intern. Med. 168: 2232-2237.
29. Ho, P.M., F.A. Masoudi, J.A. Spertus, et al. 2005. Depression predicts mortality following cardiac valve surgery. Ann. Thorac. Surg. 79: 1255-1259.
30. Raison, C.L., L. Capuron, & A.H. Miller . 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 27: 24-31.
31. Miller, A.H., V. Maletic, & C.L. Raison . 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatr. 65: 732-741.
32. Heidt, T., H.B. Sager, G. Courties, et al. 2014. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20: 754-758.
33. Lanquillon, S., J.C. Kreig, U. Bening-Abu-Scach, et al. 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379.
34. Capuron, L., G. Pagnoni, M.F. Demetrashvili, D.H. Lawson, et al. 2007. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32: 2384-2392.
35. Kenis, G., & M. Maes . 2002. Effects of antidepressants on the production of cytokines. Int. J. Neuropsychopharmacol. 5: 401-412.
36. Pace, T.W., T.C. Mletzki, O. Alagbe, et al. 2006. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatr. 163: 1630-1633.
37. Wium-Andersen, M.K., D.D. Orsted, & B.G. Nordestgaard . 2013. Elevated plasma fibrinogen, psychological distress, andidepressant use, and hospitalization with depression: two large population-based studies. Psychoneuroendocrinology 38: 638-647.
38. Topol, E.J., J.J. Ferguson, H.F. Weisman, et al. 1997. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β3 blockade with percutaneous coronary intervention. J. Am. Med. Acad. 278: 479-484.
39. Musselman, D.L., A. Tomer, A.K. Manatunga, et al. 1996. Exaggerated platelet reactivity in major depression. Am. J. Psychiatry 153: 1313-1317.
40. Pollack, B.G., F. Laghrissi-Thode, & W.R. Wagner . 2002. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J. Clin. Psychopharmacol. 20: 137-140.
41. Kuijpers, P.M., K. Hamulyak, J.J. Strik, et al. 2002. Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatr. Res. 109: 207-210.
42. Laghrissi-Thode, F., W.R. Wagner, B.G. Pollock, et al. 1997. Elevated platelet factor 4 and beta-thrombiglobulin plasma levels in depressed patients with ischemic heart disease. Biol. Psychiatr. 42: 290-295.
43. Carney, R.M., K.E. Freedland, S.A. Eisen, et al. 1995. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14: 88-90.
44. Ye, S., P. Muntner, D. Shimbo, et al. 2013. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J. Am. Coll. Cardiol. 61: 622-630.
45. Carney, R.M., R.D. Saunders, K.E. Freedland, et al. 1995. Association of depression with reduced heart rate variability in coronary heart disease. Am. J. Cardiol. 76, 562-564.
46. Nahshoni, E., D. Aravot, D. Aizenberg, et al. 2004. Heart rate variability in patients with major depression. Psychosomatics 45: 129-134.
47. Rechlin, T. 1994. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J. Clin. Psychopharmacol. 14: 392-395.
48. Kuhs, H., & G.A.E. Rudolf . 1990. Cardiovascular effects of paroxetine. Psychopharmacology 102: 379-382.
49. Scherrer, J.F., T. Chrusciel, L.D. Garfield, et al. 2012. Treatment-resistent and insuffienciently treated depression and all-cause mortality following myocardial infarction. Br. J. Psychiatr. 200: 137-142.
50. Serebruany, V.L., R.F. Suckow, T.B. Cooper, et al. 2005. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am. J. Psychiatr. 162: 1165-1170.
51. McFarlane, A., M.V. Kamath, E.L. Fallen, et al. 2001. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am. Heart J. 142: 617-623.
52. Strik, J.J., A. Honig, R. Lousberg, et al. 2000. Efficacy and safety of fluoxetine in the treatment of patients with depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med. 62: 783-789.
53. Roose, S., F. Laghrissi-Thode, J. Kennedy, et al. 1998. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. J. Am. Med. Acad. 279: 287-291.
54. Shapiro, P.A., F. Lesperance, N. Frasure-Smith, et al. 1999. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. Am. Heart J. 137: 1100-1106.
55. Glassman, A.H., C.M. O'Connor, R.M. Califf, et al. 2002. Sertraline treatment of major depression in patients with acute MI or unstable angina. J. Am. Med. Acad. 288: 701-709.
56. Berkman, L.F., J. Blumenthal, M. Burg, et al. 2003. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. J. Am. Med. Acad. 289: 3106-3116.
57. Freedland, K.E., J.A. Skala, R.M. Carney, et al. 2009. Treatment of depression after coronary bypass surgery: a randomized controlled trial. Arch. Gen. Psychiatr. 66: 387-396.
58. Sauer, W.H., J.A. Berline, & S.E. Kimmel . 2001. Selective Serotonin reuptake inhibitors and myocardial infarction. Circulation 104: 1894-1898.
59. Taylor, C.B., M.E. Youngblood, D. Catellier, et al. 2005. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatr. 62: 792-798.
60. Kim, J.M., R. Stewart, K.Y. Bae, et al. 2014. Effects of depression co-morbidity and treatment on quality of life in patients with acute coronary syndrome: the Korean depression in ACS (K-DEPACS) study. Psychol. Med. 21: 1-12.
61. DeAbajo, F.J., L.A. Rodriguez, & D. Motero . 1999. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319: 1106-1109.
62. VanWalraven, C., M.M. Mamdani, P.S. Wells, et al. 2001. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323: 655-658.
63. Wang, Y.P., Y.T. Chen, C.F. Tsai, et al. 2014 Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am. J. Psychiatr. 171: 54-61.
64. Baumeister, H., N. Hutter, & K. Bengel . 2011. Psychological and pharmacological interventions for depression in patients with coronary heart disease. Cochrane Database Syst. Rev. 9: CD008012.
65. Papakostas, G.I., R.C. Shelton, J.M. Zajecka, et al. 2014. Effect of adjunctive L-methyfolate 15 mg among inadequate responders to SSRIs in depressed patiennts who were stratified by biomarker levels and genotype: results from a randomized clinical trial. J. Clin. Psychiatr. 75: 855-863.
66. Powell, T.R., L.C. Schalkwyk, A.L. Heffernan, et al. 2013. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur. Neuropsychopharmacol. 23: 1105-1114.
67. Hashimoto, K. 2013. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog. Neurobiol. 100: 15-29.
68. Ramasubbu, R., S. Beauleau, & V.H. Taylor . 2012 The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: Diagnostic, assessment, and treatment principles. Ann. Clin. Psychiatr. 24: 82-90.
69. Lichtman, J.H., J.T. Bigger Jr., J.A. Blumenthal, et al. 2008. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118: 1768.
70. Lichtman, J.H., E.S. Froelicher, J.A. Blumenthal, et al. 2014. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic reviews and recommendations: a scientific statement from the American Heart Association. Circulation 129: 1350.